Literature DB >> 29754257

Fatal unexpected death due to familial hemophagocytic lymphohistiocytosis type 3.

Jiao Mu1, Chunting Jin2, Zhenglian Chen3, Jianfeng Li4, Bin Lv5, Hongmei Dong6.   

Abstract

Familial hemophagocytic lymphohistiocytosis is a rare autosomal recessive disorder of immune dysregulation associated with uncontrolled activation of cytotoxic T cells and macrophages. Herein, we report a case of a 14-month-old Chinese boy who presented with fever, abdominal distension and thrombopenia, and died within 3 days of admission to the hospital. Postmortem examination revealed pleuroperitoneal fluid, enlarged mesenteric lymph nodes and hepatosplenomegaly. Histopathological examination showed interstitial pneumonia, hepatonecrosis and hemophagocytosis. Immunohistochemical staining of the spleen, lymph node and liver specimens revealed numerous cytotoxic T cells (CD8+) and histiocytes (CD68+). EBER1-positive cells were observed in lymphocytes of the spleen, lymph node, liver and lungs by in situ hybridization. UNC13D mutation was identified, although the boy had no family history. The following medico-legal autopsy case is being reported for its rarity in the forensic setting. We addresses the need for genetic testing in addition to a thorough clinical history, appropriate laboratory tests, histological examination and immunohistochemical analysis for the rapid and accurate diagnosis of familial hemophagocytic lymphohistiocytosis.

Entities:  

Keywords:  Familial hemophagocytic lymphohistiocytosis; Histopathology; Thrombopenia; UNC13D

Mesh:

Substances:

Year:  2018        PMID: 29754257     DOI: 10.1007/s12024-018-9986-6

Source DB:  PubMed          Journal:  Forensic Sci Med Pathol        ISSN: 1547-769X            Impact factor:   2.007


  14 in total

1.  Familial haemophagocytic reticulosis.

Authors:  J W FARQUHAR; A E CLAIREAUX
Journal:  Arch Dis Child       Date:  1952-12       Impact factor: 3.791

2.  A platform for complementation and characterization of familial haemophagocytic lymphohistiocytosis 3 mutations.

Authors:  Edo Elstak; Arjan de Jong; Peter van der Sluijs
Journal:  J Immunol Methods       Date:  2010-12-21       Impact factor: 2.303

3.  [HLH-2004 protocol: diagnostic and therapeutic guidelines for childhood hemophagocytic lymphohistiocytosis].

Authors:  Jing-Rong Zhang; Xiao-Ling Liang; Rong Jin; Gen Lu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2013-08

4.  EBV-associated hemophagocytic syndrome.

Authors:  Konstantinos Liapis; John Apostolidis; Susan Delimpasis
Journal:  Am J Hematol       Date:  2011-05       Impact factor: 10.047

5.  Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis.

Authors:  A Santoro; S Cannella; G Bossi; F Gallo; A Trizzino; D Pende; F Dieli; G Bruno; J C Stinchcombe; C Micalizzi; C De Fusco; C Danesino; L Moretta; L D Notarangelo; G M Griffiths; M Aricò
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

6.  An uncommon presentation of EBV-driven HLH. Primary or secondary? An ongoing dilemma.

Authors:  Tânia Serrão; Alexandra Dias; Pedro Nunes; António Figueiredo
Journal:  BMJ Case Rep       Date:  2015-05-06

7.  Sudden unexpected death due to hemophagocytic lymphohistiocytosis syndrome.

Authors:  Dennis J Chute; James Rawley; John Cox; Robert J Bready
Journal:  J Forensic Sci       Date:  2013-05-17       Impact factor: 1.832

8.  Fatal virus-associated hemophagocytic syndrome in a young adult producing nontraumatic splenic rupture.

Authors:  M D Bell; R K Wright
Journal:  J Forensic Sci       Date:  1992-09       Impact factor: 1.832

9.  Rare cause of natural death in forensic setting: hemophagocytic syndrome.

Authors:  B Ondruschka; J-O Habeck; C Hädrich; J Dreßler; R Bayer
Journal:  Int J Legal Med       Date:  2015-12-30       Impact factor: 2.791

10.  Fulminant hemophagocytic lymphohistiocytosis secondary to a reactivated EBV infection: a case report.

Authors:  Pantelis Antonodimitrakis; Cecilia Wassberg; Spyridon Gerovasileiou; Johan Back; Roger Hällgren; Björn Olsen
Journal:  Ups J Med Sci       Date:  2013-03       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.